Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25. In the deal valued at $9.38 per share,5,000 shares were bought. As a result of this transaction, BIENAIME JEAN JACQUES now holds 36,415 shares worth roughly $0.62 million.
Then, BIENAIME JEAN JACQUES bought 7,800 shares, generating $60,684 in total proceeds. Upon buying the shares at $7.78, the Director now owns 31,415 shares.
Before that, SIEGALL CLAY B bought 137,100 shares. Immunome Inc shares valued at $999,459 were divested by the President and CEO at a price of $7.29 per share. As a result of the transaction, SIEGALL CLAY B now holds 806,736 shares, worth roughly $13.79 million.
Truist initiated its Immunome Inc [IMNM] rating to a Buy in a research note published on December 01, 2025; the price target was $36. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Craig Hallum began covering IMNM with “Buy” recommendation on September 05, 2025. Lake Street started covering the stock on April 02, 2025. It rated IMNM as “a Buy”.
Price Performance Review of IMNM
On Tuesday, Immunome Inc [NASDAQ:IMNM] saw its stock fall -6.71% to $17.09. Over the last five days, the stock has lost -8.36%. Immunome Inc shares have risen nearly 26.87% since the year began. Nevertheless, the stocks have risen 60.92% over the past one year. While a 52-week high of $19.16 was reached on 11/24/25, a 52-week low of $5.15 was recorded on 04/09/25.
Levels Of Support And Resistance For IMNM Stock
The 24-hour chart illustrates a support level at 16.41, which if violated will result in even more drops to 15.73. On the upside, there is a resistance level at 18.17. A further resistance level may holdings at 19.25.
How much short interest is there in Immunome Inc?
A steep rise in short interest was recorded in Immunome Inc stocks on 2025-11-14, dropping by -0.91 million shares to a total of 14.32 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 15.24 million shares. There was a decline of -6.37%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 08, 2024 when Stephens began covering the stock and recommended ‘”an Overweight”‘ rating along with a $30 price target.
